|
| A methylxanthine naturally occurring in some beverages and also used as a pharmacological agent. Caffeine's most notable pharmacological effect is as a central nervous system stimulant, increasing alertness and producing agitation. It also relaxes smooth muscle, stimulates cardiac muscle, stimulates diuresis, and appears to be useful in the treatment of some types of headache. Several cellular actions of caffeine have been observed, but it is not entirely clear how each contributes to its pharmacological profile. Among the most important are inhibition of cyclic nucleotide phosphodiesterases, antagonism of adenosine receptors, and modulation of intracellular calcium handling.
|
Pharmacological Action Central Nervous System Stimulants; Phosphodiesterase Inhibitors | Other names Vivarin; Thompson Brand 2 of Caffeine; Thompson Brand 1 of Caffeine; Seid Brand of Caffeine; Republic Drug Brand of Caffeine; Quick-Pep; Pierre Fabre Brand of Caffeine; Percutaf+¬ine; Percoffedrinol N; Passauer Brand of Caffeine; No Doz; Merck dura Brand of Caffeine; GlaxoSmithKline Brand of Caffeine; Durvitan; Dexitac; Coffeinum Purrum; Coffeinum N; Caffedrine; Bristol-Myers Squibb Brand of Caffeine; Berlin-Chemie Brand of Caffeine
| |
| Substance | CAS Registry & name | Categories | Source | Drugs*
|
8-(3-chlorostyryl)caffeine
| 148589-13-3
|
Caffeine/*analogs & derivatives.
|
FEBS Lett 1993 May 24;323(1-2):141-4
|
| caffeine citrate
| 69-22-7
|
*Caffeine *Citrates Drug Combinations.
|
Indian J Exp Biol 1980;18(1):99 | CAFCIT; CAFFEINE CITRATE
| caffeine benzoate
| 5743-17-9
|
*Benzoates *Caffeine Drug Combinations. Pharma Action Antimutagenic Agents ; Analgesics, Non-Narcotic
|
Radiobiologiia 1980;20(4):598
|
| Cafergot
| 69063-86-1
|
*Caffeine *Ergotamine Drug Combinations.
|
Clin Pediatr (Phila) 1983;22(3):226 | CAFERGOT; ERGOTAMINE TARTRATE AND CAFFEINE; MIGERGOT; WIGRAINE
| aspirin, butalbital and caffeine drug combination
| 51005-25-5
|
*Aspirin *Barbiturates *Caffeine Drug Combinations.
|
| ASPIRIN AND CAFFEINE W/ BUTALBITAL; BUTAL COMPOUND; BUTALBITAL ASPIRIN AND CAFFEINE; BUTALBITAL COMPOUND; BUTALBITAL W/ ASPIRIN & CAFFEINE; BUTALBITAL, ASPIRIN AND CAFFEINE; FIORINAL; LANORINAL
| solpadeine
| 82400-20-2
Morphinan-6-ol, 7,8-didehydro-4,5-epoxy-3-methoxy-17-methyl-, (5alpha,6alpha)-, phosphate (1:1) (salt), mixt. with 3,7-dihydro-1,3,7-trimethyl-1H-purine-2,6-dione and N-(4-hydroxyphenyl)acetamide
|
*Acetaminophen *Caffeine Codeine/*analogs & derivatives Drug Combinations.
|
J Int Med 1982;10(2):109 | ACETAMINOPHEN, CAFFEINE, AND DIHYDROCODEINE BITARTRATE; ACETAMINOPHEN, CAFFEINE, AND DIHYDROCODEINE BITATRATE; DHC PLUS; SYNALGOS-DC-A
| guarana powder
| 0
|
*Caffeine *Theobromine *Theophylline Sapindaceae.
|
Analyst 1994 Dec;119(12):2701-3
|
| xanthobine
| 10381-82-5
|
Caffeine/*analogs & derivatives.
|
Radiobiologiia 18(4):483;1978
|
Aspirin-oxycodone hydrochloride-oxycodone terephthalate combination
| 64336-56-7
|
*Aspirin *Caffeine *Oxycodone *Phenacetin Drug Combinations.
|
Kidney Int 1980;17(2):250 | CODOXY; OXYCODONE AND ASPIRIN; OXYCODONE AND ASPIRIN (HALF-STRENGTH); PERCODAN; PERCODAN-DEMI; ROXIPRIN
| Saridon
| 8064-93-5
|
*Caffeine *Phenacetin *Pyridones Antipyrine/*analogs & derivatives Drug Combinations.
|
Br J Dermatol 100(2):183;1979
|
| alnagon
| 76741-93-0
Morphinan-6-ol, 7,8-didehydro-4,5-epoxy-3-methoxy-17-methyl-, (5alpha,6alpha)-, phosphate (1:1) (salt), mixt. with 2-(acetyloxy)benzoic acid, 3,7-dihydro-1,3,7-trimethyl-1H-purine-2,6-dione and 5-ethyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione
|
*Aspirin *Caffeine *Codeine *Phenobarbital Drug Combinations.
|
Bratisl Lek Listy 71(4):421;1979 | BUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATE; FIORINAL W/CODEINE
| Excedrin extra strength
| 0
|
*Acetaminophen *Aspirin *Caffeine Drug Combinations Drugs, Non-Prescription.
|
J Pharm Pharmacol 1997 Dec;49(12):1260 | ACETAMINOPHEN, ASPIRIN AND CAFFEINE; EXCEDRIN (MIGRAINE)
| lipokinetix
| 0
|
*Benzofurans *Caffeine *Diiodothyronines *Phenylpropanolamine *Yohimbine.
|
Ann Intern Med 2002 Apr 16;136(8):590-5
|
6-thiocaffeine
| 13182-58-6
|
Caffeine/*analogs & derivatives.
|
Pharmacol Res Commun 1983;15(2):131
|
| Migril
| 86498-65-9
|
*Caffeine *Cyclizine *Ergotamine Drug Combinations.
|
Practitioner 1984;228(1390):444
|
| Vasobral
| 94423-99-1
|
*Caffeine *Dihydroergotoxine Drug Combinations.
|
Arm Radiol 1987;30(6):425
|
8-methoxycaffeine
| 569-34-6
|
Caffeine/*analogs & derivatives Cross-Linking Reagents.
|
Boll Soc Ital Biol Sper 1990;66(6):587
|
| optalidon
| 60382-50-5
5-(2-methylpropyl)-5-(2-propenyl)-2,4,6(1H,3H,5H)-pyrimidinetrione, mixt. with 3,7-dihydro-1,3,7- trimethyl-1H-purine-2,6-dione & 4-(dimethylamino)- 1,2-dihydro-1,5-dimethyl-2-phenyl-3H-pyrazol-3-one
|
*Aminopyrine *Barbiturates *Caffeine Drug Combinations.
|
Tidsskr Nor Laegeforen 99(13):635;1979
|
1-methylcaffeine
77196-81-7
1H-Purine-2,6-dione, 3,7-dihydro-3,7-dimethyl-1-(methyl-14C)
|
Caffeine/*analogs & derivatives.
|
Drug Metab Dispos 1982;10(4):417
|
| caffeidine
| 20041-90-1
|
Caffeine/*analogs & derivatives.
|
Chem Pharm Bull (Tokyo) 1986;34(9):3573
|
| Fioricet
| 122018-95-5
|
*Acetaminophen *Barbiturates *Caffeine Drug Combinations.
|
Clin Ther 1987;10(1):69 | ACETAMINOPHEN, BUTALBITAL AND CAFFEINE; ACETAMINOPHEN, BUTALBITAL, AND CAFFEINE; ACETAMINOPHEN, BUTALBITAL, CAFFEINE, AND CODEINE PHOSPHATE; ANOQUAN; BUTALBITAL, ACETAMINOPHEN AND CAFFEINE; BUTALBITAL, ACETAMINOPHEN, AND CAFFEINE WITH CODEINE PHOSPHATE; BUTALBITAL, ACETAMINOPHEN, CAFFEINE AND CODEINE PHOSPHATE; BUTALBITAL, APAP, AND CAFFEINE; ESGIC; ESGIC-PLUS; FEMCET; FIORICET; FIORICET W/ CODEINE; MEDIGESIC PLUS; PHRENILIN WITH CAFFEINE AND CODEINE
| mononitrosocaffeidine
| 145438-96-6
|
*Nitrosamines Caffeine/*analogs & derivatives.
|
Mutat Res 1993 Aug;292(1):41-9
|
| dinitrosocaffeidine
| 145438-97-7
|
*Nitrosamines Caffeine/*analogs & derivatives.
|
Mutat Res 1993 Aug;292(1):41-9
|
| Caffetin
| 0
|
*Acetaminophen *Caffeine *Codeine Antipyrine/*analogs & derivatives Drug Combinations.
|
Zh Neuropatol Psikhiatr Im S S Korsakova 1997;97(4):48-9
|
| hydroxycut
| 0
|
Caffeine *Plant Preparations.
|
Pharmacotherapy 2001 May;21(5):647-51
|
8-ethoxycaffeine
577-66-2
8-ethoxy-3,7-dihydro-1,3,7-trimethyl-1H- purine-2,6-dione
|
Caffeine/*analogs & derivatives.
|
Mutat Res 60(3):349;1979
|
| Elsinore pill
| 79992-72-6
1H-Purine-2,6-dione, 3,7-dihydro-1,3,7-trimethyl-, mixt. with (R-(R*,S*))-alpha-(1-(methylamino)ethyl)benzenemethanol
|
*Caffeine *Ephedrine Drug Combinations.
|
Int J Obes 1981;5(2):183
|
| cofplaton
| 80539-95-3
Platinate(2-), hexachloro-, (OC-6-11)-, dihydrogen, compd. with 8-(3-(dimethylamino)propoxy)-3,7-dihydro-1,3,7-trimethyl-1H-purine-2,6-dione (1:2)
|
*Organoplatinum Compounds Caffeine/*analogs & derivatives Platinum.
|
Naturwissenschaften 1981;68(12):628
|
| Midol
| 83514-22-1
Benzoic acid, 2-(acetyloxy)-, mixt. with 3,7-dihydro-1,3,7-trimethyl-1H-purine-2,6-dione, N-(4-ethoxyphenyl)acetamide and alpha-(1-(methyl(3-phenyl-2-propenyl)amino)ethyl)benzenemethanol hydrochloride
|
*Aspirin *Caffeine *Phenacetin Drug Combinations Ephedrine/*analogs & derivatives.
|
Arch Intern Med 1982;142(8):1583 | MIDOL
| Norgesic forte
| 88566-80-7
Benzoic acid, 2-(acetyloxy)-, mixt. with 3,7-dihydro-1,3,7-trimethyl-1H-purine-2,6-dione and N,N-dimethyl-2-((2-methylphenyl)phenylmethoxy)ethanamine 2-hydroxy-1,2,3-propanetricarboxylate (1:1)
|
*Aspirin *Caffeine *Orphenadrine Drug Combinations.
|
Ther Drug Monit 1983;5(4):401 | INVAGESIC; INVAGESIC FORTE; NORGESIC; NORGESIC FORTE; ORPHENADRINE CITRATE, ASPIRIN, AND CAFFEINE; ORPHENGESIC; ORPHENGESIC FORTE
| impletol depot Bayer
| 95017-34-8
Benzoic acid, 4-amino-, 2-(diethylamino)ethyl ester, mixt. with 3,7-dihydro-1,3,7-trimethyl-1H-purine-2,6-dione and 1-ethenyl-2-pyrrolidinone homopolymer
|
*Caffeine *Povidone *Procaine Drug Combinations Delayed-Action Preparations.
|
Reumatologia 1983;21(2):167
|
| ACC 30
| 0
|
*Aspirin *Caffeine *Codeine Drug Combinations.
|
Can Dent Assoc J 1986;52(4):325 | SYNALGOS-DC
| ataralgin
| 83383-37-3
|
*Acetaminophen *Caffeine *Guaifenesin Drug Combinations.
|
Act Nerv Super (Praha) 1986;28(2):153
|
8-chlorocaffeine
| 4921-49-7
|
Caffeine/*analogs & derivatives.
|
Carcinogenesis 1991;12(10):1781
|
| K1 protocol
| 0
|
*Antineoplastic Combined Chemotherapy Protocols Caffeine Cisplatin Doxorubicin Methotrexate.
|
J Cancer Res Clin Oncol 1992;118(8):567-9
|
| valcophen
| 0
|
*Aspirin *Caffeine *Phenobarbital Drug Combinations.
|
Fiziol Zh 1998;44(5-6):102-5
|
8-nitrocaffeine
| 0
|
Caffeine/*analogs & derivatives.
|
Gan To Kagaku Ryoho 2004 Apr;31(4):522-5
|
| fencamine
| 24356-67-0
8-(2-(N-methyl-beta-phenyl-alpha-methylethylamine)ethylamine)-1,3,7-trimethyl-2,6-dioxopurine
|
Caffeine/*analogs & derivatives.
|
Arzneim Forsch 24(9):1301;1974
|
| Silentan
| 79084-81-4
Ergotaman-3',6',18- | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |